![Cancers | Free Full-Text | Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients Cancers | Free Full-Text | Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients](https://www.mdpi.com/cancers/cancers-12-02958/article_deploy/html/images/cancers-12-02958-g001.png)
Cancers | Free Full-Text | Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients
![Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria | Scientific Reports Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-94191-8/MediaObjects/41598_2021_94191_Fig1_HTML.png)
Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria | Scientific Reports
Survival in IPF patients. Overall survival was defined as the time from... | Download Scientific Diagram
![A Possible Definition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes | Anticancer Research A Possible Definition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/41/8/3933/F1.large.jpg)
A Possible Definition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes | Anticancer Research
![1413 The overall survival (OS) and progression-free survival (PFS) of hyperprogressive disease (HDP) in lung cancer patients | Journal for ImmunoTherapy of Cancer 1413 The overall survival (OS) and progression-free survival (PFS) of hyperprogressive disease (HDP) in lung cancer patients | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/10/Suppl_2/A1468/F1.medium.gif)
1413 The overall survival (OS) and progression-free survival (PFS) of hyperprogressive disease (HDP) in lung cancer patients | Journal for ImmunoTherapy of Cancer
![Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download](https://images.slideplayer.com/30/9505354/slides/slide_4.jpg)
Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download
![Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX | Anticancer Research Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/7/4011/F1.large.jpg)
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX | Anticancer Research
![Definition of progression free survival and overall survival for the... | Download Scientific Diagram Definition of progression free survival and overall survival for the... | Download Scientific Diagram](https://www.researchgate.net/publication/265644752/figure/fig1/AS:269802786783234@1441337405030/Definition-of-progression-free-survival-and-overall-survival-for-the-Gold-standard-and.png)
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
![Progression-free survival. Progression-free survival was defined as the... | Download Scientific Diagram Progression-free survival. Progression-free survival was defined as the... | Download Scientific Diagram](https://www.researchgate.net/publication/303747050/figure/fig3/AS:383406182551553@1468422565156/Progression-free-survival-Progression-free-survival-was-defined-as-the-time-from-date-of.png)
Progression-free survival. Progression-free survival was defined as the... | Download Scientific Diagram
![Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11060-017-2619-1/MediaObjects/11060_2017_2619_Fig1_HTML.gif)
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
![Full article: The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This? Full article: The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?](https://www.tandfonline.com/action/showGraphicalAbstractImage?doi=10.2147%2FCMAR.S328058&id=dcmr_a_12189905_uf0001_c.jpg)
Full article: The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?
![ASCO 2023: The Relationship Between a Priori Defined Prognostic Risk Groups and Overall Survival in Men with mHSPC ASCO 2023: The Relationship Between a Priori Defined Prognostic Risk Groups and Overall Survival in Men with mHSPC](https://www.urotoday.com/images/com-doc-importer/122-asco-2023/asco-2023-the-relationship-between-a-priori-defined-prognostic-risk-groups-and-overall-survival-in-men-with-mhspc/image-3.jpg)
ASCO 2023: The Relationship Between a Priori Defined Prognostic Risk Groups and Overall Survival in Men with mHSPC
![Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-020-0805-y/MediaObjects/41416_2020_805_Fig1_HTML.png)
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
![Overall survival (OS) according to PD-L1 expression. OS was defined as... | Download Scientific Diagram Overall survival (OS) according to PD-L1 expression. OS was defined as... | Download Scientific Diagram](https://www.researchgate.net/publication/372996198/figure/fig1/AS:11431281180375622@1691583704337/Overall-survival-OS-according-to-PD-L1-expression-OS-was-defined-as-the-time-between_Q320.jpg)